Roche

Roche UK is the British subsidiary of the Swiss pharmaceutical and diagnostics company, developing innovative medicines in oncology, immunology, infectious diseases, and neuroscience. Key products include Herceptin and Kadcyla for breast cancer, Ocrevus for multiple sclerosis, Hemlibra for haemophilia A, and Tecentriq for cancer immunotherapy.